4
Changes in Ownership
ACADIA PHARMACEUTICALS INC Filed Acc 0001209191-20-042022
EVP and CCO sold 27,250 shares at an average $56.25 ($1,532,786)
- EVP and CCO acquired 27,250 shares (option exercise)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| YANG MICHAEL J. EVP and CCO | 2020-07-07 | Option exercise | +7,500 | $19.98 | $149,850 | 12,704 | D |
| YANG MICHAEL J. EVP and CCO | 2020-07-07 | Option exercise | +5,000 | $21.28 | $106,400 | 17,704 | D |
| YANG MICHAEL J. EVP and CCO | 2020-07-07 | Option exercise | +14,750 | $25.12 | $370,520 | 32,454 | D |
| YANG MICHAEL J. EVP and CCO | 2020-07-07 | Sale | −16,150 | $56.05 | $905,212 | 16,304 | D |
| YANG MICHAEL J. EVP and CCO | 2020-07-07 | Sale | −11,100 | $56.54 | $627,574 | 5,204 | D |
| Derivatives | |||||||
| YANG MICHAEL J. EVP and CCO | 2020-07-07 | Option exercise · Stock Option (Right to Buy) | −7,500 | 570,000 | D | ||
| YANG MICHAEL J. EVP and CCO | 2020-07-07 | Option exercise · Stock Option (Right to Buy) | −5,000 | 25,000 | D | ||
| YANG MICHAEL J. EVP and CCO | 2020-07-07 | Option exercise · Stock Option (Right to Buy) | −14,750 | 44,292 | D | ||
| Open-market sales · 27,250 sh · avg $56.25 · $1,532,786 | |||||||
Loading xslF345X03/doc4.xml…